PubRank

Treatment Response Among Chinese Neuromyelitis Optica Spectrum Disorders (Momentum)

Clinical Trial ID NCT04101058

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04101058

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005 24.22
2 IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005 10.39
3 International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015 6.64
4 Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol 2008 3.92
5 A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 1999 2.69
6 Visual acuity measurements. J Cataract Refract Surg 2004 2.37
7 Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J Neurol 2009 1.88
8 Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study. Neurology 2014 1.62
9 Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years. Arch Neurol 2011 1.61
10 Treatment of neuromyelitis optica: state-of-the-art and emerging therapies. Nat Rev Neurol 2014 1.53
11 Demographic and clinical features of neuromyelitis optica: A review. Mult Scler 2015 1.14
12 Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels. J Clin Neurol 2013 1.01
13 Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange. Mult Scler 2015 0.82
14 Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica. Mult Scler 2015 0.78
15 Suppressive effect of glucocorticoids on TNF-alpha production is associated with their clinical effect in multiple sclerosis. Mult Scler 2010 0.77
16 Neurodegeneration in multiple sclerosis and neuromyelitis optica. J Neurol Neurosurg Psychiatry 2016 0.76
Next 100